The cause of posterior reversible encephalopathy syndrome (PRES) is unknown. Two primary hypotheses exist: 1) hypertension exceeding auto-regulatory limits leading to forced hyper-perfusion and 2) vasoconstriction and hypo-perfusion leading to ischemia with resultant edema. The purpose of this study was to evaluate the catheter angiography (CA), MR angiography (MRA), and MR perfusion (MRP) features in PRES in order to render further insight into its mechanism of origin.
N eurotoxicity with development of posterior reversible encephalopathy syndrome (PRES) is commonly seen in association with cyclosporine and FK-506 immune suppression after transplantation (allogeneic bone marrow transplantation [allo-BMT], solid organ transplantation); preeclampsia and eclampsia; infection, sepsis, and shock; nonspecific medical renal disease; and in autoimmune conditions as well as after high-dose chemotherapy. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The mechanism behind the development of PRES is yet unproved. Two broad theories have generally been considered.
Severe hypertension with autoregulatory failure and hyperperfusion is often cited as the underlying mechanism. Alternatively, vasospasm has been demonstrated (catheter angiography [CA], MR angiography [MRA]), decreased cerebral blood flow noted (MR perfusion [MRP] , single-photon emission CT [SPECT] ) and the imaging appearance typically resembles a watershed distribution suggesting a mechanism related to brain hypoperfusion. [1] [2] [3] 5, 9, [13] [14] [15] [16] [17] [18] [19] [20] Given these opposing views, it was our opinion that parallel observations on CA, MRA, and MRP could render further insight into the state of brain perfusion in PRES. Therefore, the purpose of this study was to retrospectively evaluate the CA, MRA, and MRP features in a large group of patients with PRES.
Materials and Methods
We searched the radiology report data base at our institution (January 1998 -October 2006) for patients in whom PRES, cyclosporine, tacrolimus, and FK-506 neurotoxicity, hypertensive encephalopathy, systemic lupus erythematosus, Wegener granulomatosis, preeclampsia and eclampsia, or scleroderma were cited on brain MR imaging. MR imaging studies were reviewed in identified patients for features consistent with PRES. Criteria included complete or partial expression of the typical PRES pattern, reversibility on follow-up imaging, or vasogenic edema as demonstrated by MR diffusion-weighted imaging (DWI).
A total of 116 patients were identified with clinical neurotoxicity and imaging features consistent with PRES (infection, sepsis, and shock, 31.4%; transplantation/cyclosporine and FK-506, 31.4%; autoimmune disease, 11.4%; postchemotherapy, 5.7%; and eclampsia or delayed eclampsia, 11.4%). The remaining cases included isolated hypertension and undetermined associations.
MRA or CA, or both, were available in 47 of these 116 patients, and in 20 of 47, MRP was also obtained. These 47 patients form the basis of this retrospective evaluation and report. The Institutional Review Board approved this retrospective study.
Inpatient and outpatient records on each patient were compre-hensively reviewed with relevant clinical information identified including underlying cause/association, clinical presentation, imaging time point, and baseline/toxicity blood pressures (BP). Mean arterial pressures (MAP) were calculated in a standard fashion (MAP ϭ 2/3 diastolic ϩ 1/3 systolic pressure).
Imaging Techniques
MR imaging was performed at 1.5T (GE Healthcare, Milwaukee, Wis) including sagittal and axial T1-weighted images (TR, 600 ms; TE, min; section thickness, 5 mm; number of acquisitions, 1) fast spinecho axial proton-density (TR, 2000 -2500 ms; TE, min; section thickness, 5 mm; number of acquisitions, 1), T2-weighted (TR, 2500 -3000 ms; TE, 84 -102 ms; section thickness, 5 mm; number of acquisitions, 1). We obtained MRA using 3D time-of-flight (TOF) technique (TR, default; TE, min; FA, 45°; FOV, 18 -22 cm; Matrix, 226 ϫ 224; number of acquisitions, 1) with multiple overlapping slab reconstruction. We performed MRP using dynamic susceptibility contrast MR imaging with gradient-echo echo-planar sequence during dynamic bolus contrast administration (TR, 2040 ms; TE, 60 ms; flip angle, 60°; matrix, 96 ϫ 128; number of acquisitions, 1). Standard dose of 0.1 mmol/kg of gadolinium dimeglumine (Magnevist; Bayer HealthCare Pharmaceuticals, Wayne, NJ) or gadopentetate (ProHance; Bracco Diagnostics, Princeton, NJ) bolus injection (antecubital; 5 mL/s) was begun 10 seconds after scan initiation with a total of 40 data collection points (phases) acquired over 12 section locations.
We obtained contrast-enhanced T1-weighted images after the MRP sequence or independently with a standard dose (0.1 mmol/kg) injection using typical T1-weighted parameters, as described above. DWI (single-shot echo-planar, 10,000 ms/min/5 mm/128 [TR/TE/ section/matrix]) sequence was available in most patients. In 9 patients, CA was performed in standard fashion with common carotid/ vertebral injection and digital subtraction imaging acquisition.
Imaging Assessment-Edema Grading
PRES locations were tabulated (occipital, parietal, frontal, temporooccipital, and cerebellar). Atypical locations (brain stem, thalamus, and basal ganglia) were also noted.
MR imaging was independently graded by 2 neuroradiologists for the extent and severity of hemispheric cortex white matter edema (grade summary: 1, limited cortex white matter edema; 2, white matter cortex edema with some deep white matter extension; 3, white matter cortex edema with limited ventricle surface extension; 4, white matter cortex edema, diffuse, widely confluent, extensive ventricle contact; 5, severe white matter cortex edema, diffuse confluence, ventricle deformity) as previously described. 13 Graders were blinded to the patients' blood pressures and MRA findings. Grade differences were resolved by consensus.
Vessel and Perfusion Assessment
Vascular studies (47 patients; MRA, 43; CA, 9) were independently and blindly assessed by 2 neuroradiologists with differences resolved by consensus. Studies were graded for 2 distinct features: 1) extent of distal second-and third-order branch visualization on MRA imaging studies (best assessed in the PCA branches) and 2) presence or absence of vasculopathy (vasoconstriction, vasodilation and/or stringof-bead appearance) at CA as traditionally recognized in vasospasm or arteritis as well as the features consistent with vasculopathy of the branches of the anterior cerebral artery (ACA), middle cerebral artery (MCA), and posterior cerebral artery (PCA) on MRA.
Distal Branch Visualization (Pruning).
We assessed the extent of distal branch visualization on MRA studies by evaluating the distal branches of the PCA. Reduced branch visualization was characterized by PCA pruning and appeared as a distinct and separate observation from PCA spasm. PCA pruning was recognized by reduced PCA length (independent of vessel irregularity). Grade of PCA visualization was based on the length of calcarine artery visualization. PCA pruning was graded in severity on a 3-point scale and reviewed in Table 1 .
MCA pruning was also noted if typically identified MCA branches demonstrated tapering and reduced visualization. The distal MCA branches were not consistently included on the 3D TOF sequence because of choice of placement of the upper margin of the slab. For this reason, observations of MCA pruning were made if available, but the MCA was not used for grading.
Vasculopathy. The 2 primary features of vasculopathy were tabulated separately: 1) diffuse vessel constriction or narrowing, 2) focal vessel irregularity of first-, second-, and third-order branch vessels (focal vasoconstriction, focal vasodilation, and beaded or string-ofbead appearance). 21, 22 Diffuse vasoconstriction (narrowing or constriction) was considered present if significant diffuse vessel caliber reduction was observed in 2 or more major branch groups (ACA, MCA, and PCA). We judged focal vessel irregularity using the traditional features of vasospasm and arteritis and graded on a 4-point scale (0, normal; 1, possibly abnormal [mild vessel irregularity]; 2, moderate vessel irregularity; and 3, severe vessel irregularity). Judgment of vessel abnormality (pruning, vasoconstriction, vasodilation, string-of-bead appearance) was referenced relative to typical benchmark normal MRA features obtained at our institution. Objective reference criteria were used to confidently grade vessel irregularity as vasculopathy: 1) a distinct change in artery caliber/morphology between 2 MRA studies, 2) correlation with catheter angiogram, 3) significant difference in vessel caliber/morphology relative to an internal patient reference, 4) age-inappropriate vessel caliber or irregularity in a young patient, and 5) obvious intrinsically abnormal ACA, MCA, and PCA branches with focal spasm and pruning or diffuse vasoconstriction.
MR Perfusion. We performed postprocessing using the FuncTools (GE Healthcare) workstation. Relative cerebral blood volume (rCBV) was obtained from quantification of the area under the negative enhancement integral generated. Negative enhancement integral was obtained in a standard fashion computing the area under the negative enhancement curve generated during bolus contrast arrival, with brain enhancement beginning at initiation of loss of signal intensity and continuing to the point of re-establishment of the postenhancement baseline signal intensity. Regional rCBV region-of-interest measurements were obtained in a healthy-appearing cortex and white matter as well as areas affected with PRES as identified on MR imaging (FLAIR sequence and T2*). Establishing a baseline healthy cortex rCBV was challenging because of 1) altered brain blood flow in a normal-appearing brain (possibly because of intrinsic vasculopathy) and 2) potential volume averaging with cortical vessels. Computed rCBV was often mildly reduced in normal-appearing regions of the brain, in particular, the typical watershed and regions immediately adjacent to the PRES lesions.
Therefore, regions were chosen as representative of normal that had the consistently greatest rCBV in a healthy-appearing brain (typically medial frontal and parietal cortex, frontal operculum, and lateral superior temporo-occipital junction). Regions of interest were chosen to avoid visibly linear high flow from surface blood vessels that would inappropriately increase the rCBV measurements in a healthy cortex.
Normal rCBV was established averaging 10 to 20 region-of-interest maximum measurements (2-4 mL voxel) with a healthy-appearing cortex. The regions of interest were chosen to avoid visibly linear high flow from surface blood vessels that would inappropriately increase the rCBV measurements.
In the PRES lesions, 2 to 8 cortex measurements were obtained over moderate-sized focal lesions or over representative confluent regions, with careful attention not to alter measurements by extending into adjacent white matter or including dominant surface vessels. All lesion and healthy-appearing brain measurements were agreed on by consensus. Average lesion rCBV was referenced to average healthy brain rCBV obtained for that patient.
Statistics
We evaluated the statistical significance of edema grade relative to blood pressure at toxicity using the Student t test and Kruskal-Wallis extension of the Wilcoxon test (PROCAPABILITY, SAS software package release 8.2; SAS Institute, Cary, NC). Observation timing effect on edema and PCA grades were tested by Kruskal-Wallis extension of the Wilcoxon test and analysis of variance. Interobserver differences for edema and PCA grades were tested by percentage agreement. The statistical significance of edema grade relative to PCA pruning and visualization grades was evaluated with the linear-bylinear association test for row and column independence, in which rows and columns have natural ordering.
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Results
The clinical characteristics of the 47 patients with PRES on CA, MRA, and MRP are reviewed in Table 2 and On-line Table 1 . There were 8 patients who were men and 39 who were women, with an average age of 44.6 years (range, 19 -79 years) with clinical associations as tabulated (eclampsia or delayed eclampsia,11; transplantation, 9 [cyclosporine and FK-506]; autoimmune disease, 5; postchemotherapy, 2; and infection, sepsis, and shock, 17). PRES was associated with drug use for hypertension (1 patient), recently developed hypertension (1 patient), and unstable hypertension or previous renal cell carcinoma (1 patient).
Presentation at toxicity included headache, change in vision, and change in mental status alone (19 patients) or followed by seizure (21 patients), with seizure only in 7 patients. In 11 patients, toxicity BP was either normal (baseline) or demonstrated minor increase in systolic pressure (average MAP, 94 mm Hg; range, 86 -104 mm Hg). Other than minor fluctuations in BP as is commonly seen in patients in the intensive care unit, no significant episodes of hypertension were noted in the pretoxicity or peritoxicity period in these patients. Toxicity BP was moderately elevated in 5 patients (average MAP, 114 mm Hg; range, 110 -115 mm Hg, typically with moderate diastolic pressure elevation) and severely elevated in 31 patients (average MAP, 133 mm Hg; range, 119 -177 mm Hg; significant systolic pressure elevation, diastolic pressure elevation, or both). BP in these patients was typically unstable immediately before and after toxicity and was often difficult to control after development of neurotoxicity and PRES.
Vasogenic edema was identified in typical PRES locations (occipital, 44 patients; parietal, 45 patients; frontal, 36 patients; temporooccipital junction, 22 patients; and cerebellum, 19 patients) and atypical locations (brain stem [pons, 5 patients; medulla, 2 patients; midbrain, 3 patients]); basal ganglia, 4 patients; and thalamus, 6 patients). Of 32 patients, DWI results were normal or demonstrated T2 shinethrough in 16. In 7 patients, DWI results were normal except for a single focus of restricted diffusion (infarction, 7 patients; hemorrhage, 3 patients). Minimal stippled cortical enhancement was noted in 3 patients. Early follow-up imaging results demonstrated improvement in vasogenic edema in 12 patients with complete reversal of the PRES pattern in 19 patients. Follow-up imaging was not obtained in 16 patients, but DWI results in these patients were normal or demonstrated T2 shinethrough.
Vasogenic Edema and MAP
Greater hemispheric edema was present in patients who were normotensive (grade average, 2.45) with reduced edema in patients with moderate to severe hypertension (grade averages, 1.6 and 1.74, respectively). The difference between patients who were normotensive and those with severe hypertension was statistically significant (P ϭ .045, Student t test). Patients with eclampsia and autoimmune disease primarily demonstrated severe hypertension and a low grade of vasogenic edema, whereas patients with infection, sepsis, and shock were commonly normotensive with more severe brain edema (Table 2 and On-line Table 1) .
No statistically significant difference was detected in edema grade relative to MR imaging timing from recognized neurotoxicity. Interobserver agreement of edema grade was 60.4% before consensus resolution.
Angiographic Features (CA and MRA)
In 46 of 47 patients, intracranial vessels could be assessed by CA (9 patients) or MRA (43 patients). In 1 patient with severe hypertension, MRA could not be assessed because of significant motion artifact. The MRA and CA features in patients with PRES are summarized in Table 3 and On-line Table 1 , and in Figs 1-5. 
Conventional Angiography in PRES
Vasculopathy was identified in 8 of 9 patients with CA demonstrating focal vasoconstriction, focal vasodilation, a stringof-bead appearance in at least 1 major arterial territory, or all 3 of these features. Involvement was most commonly in the second-and third-order branches but was also identified in fourth-order vessels and was frequently associated with regions of PRES vasogenic edema. Delay or reduced capillary blush was noted in all 9 patients (typically interhemispheric region, parietal-occipital lobes, or in areas of PRES vasogenic edema).
MRA was available in 6 of 9 patients with CA. In 3 of 6 patients, severe vessel irregularity consistent with vasculopathy (grade 2-3) was present on MRA and corresponded to the CA findings (Figs 1-3 ). In one of these patients (Fig 3) , follow-up MRA demonstrated reversal of diffuse and focal vasoconstriction and vasodilation with worsening noted in the second patient.
In the other 3 patients, initial MRA demonstrated moderate to severe vessel irregularity and diffuse vasoconstriction, with follow-up CA demonstrating partial reversal with subtle residual vasculopathy in 2 and delayed or reduced interhemispheric capillary blush in 1.
MRA in PRES
MRA was obtained in the immediate toxicity period (0 -3 days) in 40 patients and at 4, 8, and 10 days after development of PRES in 3. Follow-up MRA was available in 11 of 43 patients.
MRA with Follow-Up
In 7 of 11 patients, follow-up MRA demonstrated reversal of diffuse vasoconstriction with a distinct, and often marked, increase in vessel size and diameter along with improved visualization of the distal branch (On-line Table 1 ). Improved distal PCA visualization only was noted in 2 patients, and in 2 patients (each studied again at 4 days), follow-up MRA demonstrated worsening vessel irregularity and reduced branch visualization.
In patients demonstrating improvement, complete or near-complete normalization of vessel irregularity and vasculopathy was identified in 5 (follow-up imaging at 3, 11, 30, 90, and 162 days; Fig 3) , improvement but still-obvious vessel irregularity in 3 (follow-up imaging at 2, 3, and 4 days), and significantly improved distal PCA visualization with improved, but persistent, vessel irregularity in 1 patient with sickle cell disease followed up at 33 days.
Overall MRA and CA Observations At MRA, diffuse vasoconstriction and focal vasculopathy were more frequently noted in patients with moderate to severe hypertension with vessel pruning, mild irregularity, or healthy appearance noted in patients who were normotensive (Table 3 and On-line Table 1 and Figs 1B, 2C, 3B, 2-3) , or vessel pruning. First-order branch spasm was identified in 5 patients with possible mild first-order spasm in an additional 6 patients. Second-and third-order focal branch spasm was identified by CA and MRA in 33 of 46 patients.
MRA and Vasogenic Edema Comparison in Patients Who
Were Severely Hypertensive Extent of PCA pruning relative to the extent of hemispheric edema was compared in the patients who were severely hypertensive and are summarized in Table 4 . Vasogenic edema was less in patients who demonstrated lengthy visualization of the PCA and calcarine artery (Fig 5) with more severe edema in those patients with moderate to severe PCA pruning (Fig 4) .
Therefore, hemispheric edema trended downward with greater visualized length of the PCA and calcarine arteries, which was statistically significant (P ϭ .002). The observation remained statistically significant when only the 25 patients imaged within 1 day of toxicity (P ϭ .003) were considered. No statistically significant difference was detected in the PCA grade relative to the timing of the MR image from recognized neurotoxicity. Interobserver agreement of the PCA grade was 86% before consensus resolution.
MRP in PRES
In 15 of 20 patients, the MRP studies were of good quality, and reliable measurements of rCBV could be made with 5 studies not evaluated because of an irregular bolus or motion artifact. There were 70 abnormal-appearing lesions or regions present in the 15 patients, with reliable rCBV measurements made in 59 of these 70 locations (On-line Table 2 and Fig 6) .
In 51 (86%) of 59 PRES lesions and regions, rCBV was markedly diminished (Յ80%; average, 61% Ϯ 12%; range, 31%-80%) compared with the healthy reference cortex. In 8 studied lesions, rCBV was between 84% and 99% of the healthy cortex rCBV (single lesion in 5 patients, 3 lesions in 1 patient studied 3 days after toxicity). Overall average rCBV in all measured PRES lesions and regions relative to a reference normal cortex rCBV was 65.2% Ϯ 14.8% (range, 31%-99%).
Discussion
The cause of PRES is not established. Classically, neurotoxicity with PRES is associated with cyclosporine and FK-506 (transplantation), preeclampsia and eclampsia, autoimmune disease, and postchemotherapy. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 24 The mechanism of PRES remains controversial. Severe hypertension with autoregulatory failure and forced hyperperfusion remains widely accepted. Alternatively, vasospasm is reported (MRA or CA), and reduced perfusion has been The autoregulatory response is intended to maintain stable cerebral blood flow in the face of blood pressure fluctuations. 25, 26 With acute severe hypertension, precapillary arteriolar vasoconstriction occurs in small (30 -300 ) resistance vessels that limit cerebral blood flow (upper-limit-of-response MAP, 140 -160 mm Hg in patients who are normotensive). [25] [26] [27] [28] [29] This seems to be regulated by the endothelium through effects of elevated transmural pressure and release of thromboxane A2 and endothelin. 26 The upper limit is increased in the setting of essential hypertension and sympathetic stimulation as may exist in patients with cyclosporine toxicity. 25, 27 Above this upper-threshold MAP, passive vasodilation ensues with subsequent increase in CBF and endothe- lial fluid transudation. 26, 27 Vasoconstriction and vasodilation have been noted in animal studies of acute severe hypertension, but these changes typically require MAP to exceed 180 to 200 mm Hg. 28, 29 Although this theory remains popular, toxicity MAP is identified at this critical level (MAP Ͼ 140 -160 mm Hg) in only a small subset of patients who develop PRES. In addition, blood pressure at toxicity is within the normal range or is only minimally elevated in 20% to 30% of patients with PRES. 5 Our results at catheter angiography confirm a high incidence of vascular abnormality in PRES (focal vasoconstriction, focal vasodilation, and string-of-bead appearance) and demonstrate that these observations are reflected in the pattern seen at MRA. Results of follow-up MRA demonstrated reversibility of this vas- culopathy with normalization of diffuse vasoconstriction, reversal of focal vessel irregularity, and reduced vessel pruning consistent with previous reports. 13, 14 In addition, MRP results demonstrated significantly reduced rCBV in most regions of PRES imaging abnormality compared with a reference healthy cortex. The observations in our patients are consistent with the vasculopathy and hypoperfusion in PRES.
In most of our patients, PRES developed after transplantation (cyclosporine and FK-506), infection, sepsis, shock, and eclampsia, all associated with systemic inflammation, endothelial activation and injury (upregulation of E-selectin, Pselectin, and intercellular adhesion molecule), and significant release of cytokines (tumor necrosis factor-alpha [TNF-␣] and interleukin-1 [IL-1]). [30] [31] [32] [33] [34] [35] Endothelial activation and injury could independently inhibit flow or promote increased white cell and platelet adherence with subsequent blood flow effects at the capillary or venule level. 36, 37 TNF-␣ and IL-1 promote endothelin-1 production and platelet degranulation could affect vessel tone, resulting in vasoconstriction. 38, 39 These conditions also develop endothelial injury with hemolysis (red cell fragmentation, increased lactate dehydrogenase), capillary leakage with peripheral edema, and organ hypoperfusion. Vascular instability is common in preeclampsia, eclampsia, sepsis, and shock with both vasoconstrictive effects (platelet degranulation with thromboxane release, endothelin-1, angiotensin, vasopressin, and central sympathetic stimulation) and vasodilatory effects (nitric oxide, prostacyclin) noted. 30, 31 Brain vasculature may be experiencing a similar alteration that is considered responsible for the systemic effects that lead to organ hypoperfusion in these conditions (endothelial activation, white cell trafficking, cerebral vasoconstriction). In the setting of significant hypoxemia, endothelial cells become activated and vascular endothelial growth factor mRNA (vascular endothelial growth factor (VGEF), previously known as vascular permeability factor) can upregulate with increased tissue levels of VGEF within 6 to 24 hours. 40 Sustained hypoperfusion and hypoxemia could result in expression of VEGF leading to endothelial leakage and vasogenic edema in PRES.
The features of vasoconstriction and vasodilation were identified in medium and small arteries (Ͼ300 ) even in the absence of significant hypertension. Vessel imaging appearance at CA and MRA might be reflecting the combined effects of both increased vessel tone (diffuse and focal vasoconstriction) and decreased tone (focal vasodilation) as can occur with induced endothelial injury or dysfunction. 26 PRES also occurred in patients with autoimmune diseases (ie, systemic lupus erythematosus), conditions with a known tendency to develop what is traditionally labeled arteritis.
Although only a small portion of our patients with PRES were studied with MRP, measurements of rCBV parallel results of other studies. In 51 (86%) measured lesions, rCBV was significantly reduced (average, 61%) compared with a healthy cortex. This is consistent with a case reported by Engelter et al 19 in which a rCBV lesion was 69% compared with healthy white matter). Brubaker et al 20 reports a somewhat lower average rCBV (28%) comparing the affected posterior part with the unaffected anterior part of the brain. This difference might be related to differing methodology or relatively small numbers of patients in both of our study groups.
Pruning and tapering of the PCA seems distinct from the observation of diffuse constriction and focal spasm of the PCA, though overlap was noted in many of our patients. Resistance to organ flow is primarily at the arteriole, capillary, or venule. If vasculopathy is present and resistance to brain blood flow is increased, arterial flow velocity will likely decrease with reduced vessel visualization on the 3D TOF MRA sequence. This could explain the pruned and tapered appearance.
Although severe vessel irregularity noted at MRA may appear nonspecific, these features, at least in part, reflect vascu- 
PRES and Hypertension
PRES developing and spontaneously reversing in patients who are normotensive suggests a mechanism other than hypertension for the development of vasogenic edema. As graded in our study, vasogenic edema in patients with moderate and severe hypertension was not greater but actually was reduced compared with patients who were normotensive (P ϭ .045 between patients who were normotensive and those who were severely hypertensive). Most patients who were severely hypertensive demonstrated long-segment visualization of the PCA (despite diffuse vasoconstriction and focal spasm), and in these patients, more lengthy visualization of the PCA (PCA pruning grade 1) was associated with reduced brain edema (P ϭ .002). If failed autoregulation with passive vasodilation and hyperperfusion were the mechanism in PRES (with or without endothelial injury), one would expect the opposite observations including 1) a greater degree of edema in the severe hypertensive group compared with the normotensive group (accompanied by long-segment PCA visualization) and 2) a greater degree of vasogenic edema within the severe hypertensive group in those with greater PCA visualization. Increased perfusion pressure might, at some point in the evolving systemic process, help maintain brain blood flow in the face of increased vascular resistance and hypoxemia, suggesting a protective effect. Elevated blood pressure and systemic vasoconstriction could be a reactive response (Cushing effect, biocontrol mechanism) designed to maintain adequate organ perfusion at the microvascular level. Of potential importance, severe systemic hypertension developing in the face of an increased state of vasoreactivity might augment cerebral vasoconstriction (through autoregulation) and, like a biologic feedback loop, function to worsen hypoperfusion, endothelial dysfunction, or endothelial injury.
Several limitations of our study existed because of the retrospective nature of this evaluation. Standardized imaging timing and techniques (MRA, MRP, and brain imaging), computer modeling of vasogenic edema, broader clinical data recording (cytokines), and treatment may be of benefit. It is without doubt that a prospective assessment of PRES would be important.
Conclusion
CA, MRA, and MRP demonstrate evidence of vasculopathy with focal and diffuse vasoconstriction, focal vasodilation, and a string-of-bead pattern along with reduced rCBV suggesting a state of brain hypoperfusion in PRES. Vasogenic edema was lower in patients who were hypertensive compared with those who were normotensive (P Ͻ .05). In the patients who were severely hypertensive, better PCA visualization correlated with reduced vasogenic edema (P ϭ .002).
These features suggest that the primary abnormality in PRES could be related to reduced cerebral blood flow and that hypertension may, at some level, exert a protective effect limiting the developing of PRES and improving compromised cerebral perfusion. Patient 41 is a 34-year-old woman with baseline blood pressure of 104/60 mm Hg who at 33 weeks of pregnancy developed preeclampsia (toxicity blood pressure of 153/102 mm Hg) followed by seizures and status epilepticus. She ultimately required cesarean delivery for seizure control. A, Axial MR imaging (FLAIR sequence) demonstrates typical PRES vasogenic edema in the parietal regions (curved arrows) bilaterally and was judged edema, grade 2. Frontal and occipital involvement was also present bilaterally (not shown). B, rCBV color map demonstrates decreased perfusion in the region of the right parietal lesion (curved arrow). Lesion rCBV was 65% relative to a reference healthy cortex.
